F
FYR Diagnostics
Diagnostic tools for diseases with unmet clinical needs, specializing in COVID-19 variant tracking and testing
About FYR Diagnostics
Our team brings together unique skill sets to tackle some of the world’s most devastating and burdensome diseases in both human healthcare and agriculture.
Our development pipeline includes various diagnostic technologies and supporting devices. Our ability to quickly adapt and utilize novel technologies allows us to develop solutions for widely unmet diagnostic needs that offer a true competitive advantage.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Missoula, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Two Bear Capital
Sontag foundation
Yuvaan Tiwari Foundation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about FYR Diagnostics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FYR Diagnostics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.